CHRNA3
protein-codingcholinergic receptor nicotinic alpha 3 subunit, the group of Cholinergic receptors nicotinic subunits
Gene summary
This locus encodes a member of the nicotinic acetylcholine receptor family of proteins. Members of this family of proteins form pentameric complexes comprised of both alpha and beta subunits. This locus encodes an alpha-type subunit, as it contains characteristic adjacent cysteine residues. The encoded protein is a ligand-gated ion channel that likely plays a role in neurotransmission. Polymorphisms in this gene have been associated with an increased risk of smoking initiation and an increased susceptibility to lung cancer. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~28.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0008630
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0008630
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Neurologic; Renal
Intervention: Renal
Rationale: The condition can involve chronic kidney disease andrecurrent urinary tract infections, and awareness may allow prompt diagnosis and management (of note, surgical management of VUR has not been reported as effective)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CHRNA3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000743.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 33 | 4 | 41 | ||
| missense | 103 | 5 | 2 | 110 | ||
| nonsense | 1 | 4 | 1 | 6 | ||
| start loss | 1 | 1 | ||||
| frameshift | 4 | 5 | 1 | 10 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 6 | 11 | 109 | 38 | 6 | 170 |
Highest pathogenic variant AF is 0.00024533735
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000734.2 | 6 | MANE Select | |
| Ensembl | ENSP00000315602.5 | 6 | MANE Select | |
| RefSeq | NP_001160166.1 | 6 | Standard | |
| Ensembl | ENSP00000267951.4 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Neuroactive ligand-receptor interaction - Homo sapiens (human)
- Cholinergic synapse - Homo sapiens (human)
- Nicotine Pathway (Dopaminergic Neuron), Pharmacodynamics
- Nicotine Pathway (Chromaffin Cell), Pharmacodynamics
- Nicotine Metabolism Pathway
Biological Process
- ion transport
- regulation of smooth muscle contraction
- signal transduction
- activation of transmembrane receptor protein tyrosine kinase activity
- chemical synaptic transmission
Molecular Function
- extracellular ligand-gated ion channel activity
- protein binding
- ligand-gated ion channel activity
- acetylcholine receptor activity
- acetylcholine-gated cation-selective channel activity
Cellular Component
- plasma membrane
- integral component of plasma membrane
- acetylcholine-gated channel complex
- postsynaptic density
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000326828
- Coding exons
- 6
- Length
- 28244
- Individuals with no LoFs
- 125642
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 106
- Defined
- 125748
- p
- 0.000422
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.735 | 247 | 282 | 0.877 | 0.0000166 | 3288 |
| Missense (PolyPhen) | 119 | 155.9 | 0.76331 | 1816 | ||
| Synonymous | -2.55 | 158 | 122 | 1.29 | 0.00000842 | 1016 |
| Loss of Function | 1.09 | 13 | 18.0 | 0.722 | 7.67e-7 | 226 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00049 | 0.00049 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00044 | 0.00044 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00051 | 0.00051 | rare |
| South Asian | 0.00065 | 0.00065 | rare |
| Other | 0.00082 | 0.00081 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.;
Recessive Scores
- pRec
- 0.252
Intolerance Scores
- LoFtool
- 0.0990
- RVIS EVS
- -1.11
- RVIS percentile EVS
- 6.78
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.159
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |